Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04684680
Other study ID # aswu/3oo/6/19
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2021
Est. completion date November 1, 2021

Study information

Verified date August 2021
Source Aswan University Hospital
Contact Hany f Sallam, md
Phone +201022336052
Email hanygyne@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the efficacy of drinking zamzam water versus tap water in increasing the AF index in women with oligohydramnios.


Description:

Oligohydramnios refers to decrease in amniotic fluid and it is defined as a deepest fluid pocket of less than 2 cm or an amniotic fluid index of 5 cm or less. Oligohydramnios complicates 0.5% to 8% of pregnancies, and 12 % if postdates When it occurs in first half of pregnancy it is associated with birth defects while in second half it causes poor fetal growth, malpresentations , FHR decelerations , MAS , Fetal suicidal syndrome and increases cesarean section and management and prognosis depend on gestational age


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date November 1, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - pregnant female with idiopathic oligohydramnios Exclusion Criteria: - patients with medical disorder - congenital anomalies - premature rupture of membrane - Patient refuse to participate

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
zamzam water
will receive the normal need of daily requirement of water (2.5 liter) in form of zamzam water till patients deliver or till term
tap water
will receive the normal need of daily requirement of water (2.5 liter) in form of tap water

Locations

Country Name City State
Egypt Aswan University Hospital Aswan

Sponsors (1)

Lead Sponsor Collaborator
Aswan University Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary amniotic fluid index the change of the amniotic fluid volume 10 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03277417 - Does Amniotic Fluid Index Affect the Fetal Cardiac Performance? N/A
Recruiting NCT00787163 - Amnioinfusion Initiative Phase 3
Completed NCT05059093 - Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Not yet recruiting NCT05043753 - "Fetal gRowth AbnorMality dEtection Trial" N/A
Recruiting NCT02997345 - PPROM Registry (Preterm Premature Rupture of Membranes)
Completed NCT03935607 - The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid Index
Completed NCT02581774 - Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term Phase 4
Terminated NCT01569035 - Warfarine in Unexplained Oligohydramnios Phase 4
Completed NCT01140971 - Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of Labor N/A
Not yet recruiting NCT03815968 - Low Sodium Diet in Oligohydramnios Assigned for Conservative Management N/A
Enrolling by invitation NCT04451109 - Dilapan-S®: A Multicenter US E-registry
Recruiting NCT02901340 - Fetal Renal Artery Doppler Indices in Borderline Isolated Oligohydramnios N/A
Terminated NCT01682928 - Hydrotherapy for the Reversal of Oligohydramnios N/A
Not yet recruiting NCT05474326 - Effect of Intermittent Pneumatic Compression Device of Lower Limbs in Oligohydramnios N/A
Completed NCT05332015 - The Effect of Oral Hypotonic Hydration in Isolated Oligohydramnios N/A